GFC-M

G.F.C Green Fields Capital Ltd.

IL Healthcare Biotechnology

Latest week
3 Jul 2026
Close
16.030001
Fair value
12.337346
Next-week expectancy
Negative 25.03%
Sharemaestro

GFC-M Chart Pack

G.F.C Green Fields Capital Ltd.

Exchange
TLV
Latest week
3 Jul 2026
Close
16.030001
Fair value
12.337346
Next-week expectancy
Negative 25.03%
Generated
21 Jul 2026 14:44
Sector
Healthcare
Industry
Biotechnology

Chart Summary

Over the latest 12 completed weeks ending 2026-07-03, GFC-M rose 7.22%, moving from 14.95 to 16.03. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 2.92 and has improved across the 12-week window. Market Dynamics is 0.11 on the latest week. Next-week expectancy is negative at 25.03% based on similar historical setup states.

Key Points

Week Ending
3 Jul 2026
Latest Close
16.03
12-Week Change
7.22%
Trend Signal
Active
Next-Week Expectancy
Negative 25.03%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
2.92
Market Dynamics
0.11

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
3 Jul 2026
Latest Close
16.03
12-Week Change
7.22%
Trend Signal
Active
Next-Week Expectancy
Negative 25.03%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
2.92
Market Dynamics
0.11

Over the latest 12 completed weeks ending 2026-07-03, GFC-M rose 7.22%, moving from 14.95 to 16.03. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 2.92 and has improved across the 12-week window. Market Dynamics is 0.11 on the latest week. Next-week expectancy is negative at 25.03% based on similar historical setup states.

Industry Peers

Israel equities in Biotechnology

Stock Exchange Week Open High Low Close Change
EVGN Evogene Ltd. TLV 17 Jul 2026 1.50 1.75 1.35 1.73 15.00%
BOLT BioLight Life Sciences Ltd. TLV 17 Jul 2026 3.69 4.14 3.69 4.07 10.25%
PLUR Pluri Inc. TLV 17 Jul 2026 5.30 5.95 4.85 5.70 7.51%
HDST-M HBL - Hadasit Bio-Holdings Ltd TLV 17 Jul 2026 0.72 0.72 0.72 0.72 0.00%
PPBT Purple Biotech Ltd TLV 17 Jul 2026 0.01 0.01 0.01 0.01 0.00%
XTLB XTL Biopharmaceuticals Ltd. TLV 17 Jul 2026 0.02 0.02 0.02 0.02 0.00%
ORMP Oramed Pharmaceuticals Inc. TLV 17 Jul 2026 12.54 12.54 11.80 12.21 -2.63%
CANF Can-Fite BioPharma Ltd. TLV 17 Jul 2026 5.01 5.50 4.80 4.86 -3.05%
CBI Clal Biotechnology Industries Ltd. TLV 17 Jul 2026 0.27 0.28 0.26 0.26 -3.32%
BONS Bonus BioGroup Ltd. TLV 17 Jul 2026 0.29 0.30 0.26 0.28 -3.45%
CGEN Compugen Ltd. TLV 17 Jul 2026 7.45 7.45 6.64 7.15 -4.13%
MTLF Matricelf Ltd TLV 17 Jul 2026 2.73 2.73 2.57 2.61 -4.36%
BLRX BioLineRx Ltd. TLV 17 Jul 2026 0.02 0.02 0.01 0.01 -6.67%
LCTX Lineage Cell Therapeutics, Inc. TLV 17 Jul 2026 4.09 4.09 3.50 3.76 -8.05%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.